Roche Lung Cancer Drug Succeeds in Clinical Trial

Swiss pharmaceutical giant Roche just announced a breakthrough clinical trial success for divarasib, a new drug targeting a hard-to-treat form of lung cancer.

The therapy showed promising results as a second-line treatment without introducing new side effects.